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Zinc deficiency causes delayed ATP clearance
and adenosine generation in rats and cell culture
models
Taka-aki Takeda1, Shiho Miyazaki1, Miki Kobayashi1, Katsutoshi Nishino1, Tomoko Goto2,5, Mayu Matsunaga1,
Minami Ooi2, Hitoshi Shirakawa2, Fumito Tani3, Tatsuyoshi Kawamura4, Michio Komai2 & Taiho Kambe 1
Zinc deficiency causes myriad pathophysiological symptoms, but why distinct phenotypes are
generated by zinc deficiency remains unclear. Considering that several ectoenzymes involved
in purinergic signaling through extracellular adenine-nucleotide hydrolysis possess zinc ions
in their active sites, and disorders in purinergic signaling result in diverse diseases that are
frequently similar to those caused by zinc deficiency, herein we examine whether zinc
deficiency affects extracellular adenine-nucleotide metabolism. Zinc deficiency severely
impairs the activities of major ectoenzymes (ENPP1, ENPP3, NT5E/CD73, and TNAP), and
also strongly suppresses adenine-nucleotide hydrolysis in cell-membrane preparations or rat
plasma, thereby increasing ATP and ADP levels and decreasing adenosine levels. Thus, zinc
deficiency delays both extracellular ATP clearance and adenosine generation, and zinc
modulates extracellular adenine-nucleotide metabolism. Since the finely tuned balance
between extracellular adenine nucleotides and adenosine is critical for purinergic signaling,
these findings provide a novel insight into why zinc deficiency results in diverse symptoms.
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Zinc is a trace nutrient indispensable for life. It plays crucialroles in numerous biological processes, and thus, its defi-ciency causes myriad pathophysiological symptoms in
human patients and animal models. The representative symp-
toms include persistent diarrhea, severe dermatitis, chronic
inflammation, alopecia, taste disorders, immune insufficiency,
brain dysfunction, impaired wound healing, loss of appetite,
growth retardation, liver disease, and neuropsychological changes
such as emotional instability, irritability, and depression
(reviewed in refs. 1–12). The recent definition of neuromodulatory
functions of zinc can explain the association between zinc and
neurodegenerative diseases under zinc deficiency13,14. Further-
more, the regulatory roles of zinc in insulin metabolism can
suggest its association with dysregulation of glucose metabolism
under zinc deficiency15,16. However, the potential reasons for the
many symptoms associated with zinc deficiency have still not
been well elucidated. In contrast, iron deficiency mainly results in
anemia due to the higher iron content in red blood cells.
Addressing this critical question regarding zinc deficiency can
potentially lead to novel therapeutic applications of zinc to
improve human health. Importantly, these pathophysiological
symptoms caused by zinc deficiency are often similar to those
caused by dysfunctions in purinergic signaling.
In purinergic signaling, extracellular adenine nucleotides and
adenosine produce diverse effects in a cell-specific manner, and
these effects are mediated by P2 and P1 receptors. Extracellular
ATP triggers signaling events through numerous P2 (P2X and
P2Y) receptors, and ADP hydrolyzed from ATP also triggers P2Y
receptor signaling (Fig. 1). In contrast, adenosine, hydrolyzed
from ATP through ADP and AMP, elicits a distinct signaling
response through P1 adenosine receptors. Because P2 and P1
receptors frequently transduce signals that produce opposite
effects, the resulting cellular response is attributable to the ratio of
both ATP and ADP to adenosine and is thus involved in both
physiology and pathophysiology in distinct manners17–22.
Extracellular adenine nucleotides and adenosine are metabolized
by several adenine-nucleotide-hydrolyzing ectoenzymes that
mediate the hydrolysis from ATP to adenosine through ADP and
AMP. Thus, the complex and integrated network of these
enzymes is considered to govern the duration and magnitude
of purinergic signaling. The ectoenzymes are divided into
five principal groups/enzymes (Fig. 1): the ectonucleotide
triphosphate diphosphohydrolase (ENTPDase) family, the ecto-
nucleotide pyrophosphatase/phosphodiesterase (ENPP) family,
the ecto-5′-nucleotidase (NT5E, also known as CD73), the alka-
line phosphatase (ALP) family, and prostatic acid phosphatase
(PAP)17,18,20,22. Specifically, the ENTPDase-family proteins play
pivotal roles in the hydrolysis of extracellular ATP to ADP and
ADP to AMP23. The ENPP proteins, particularly ENPP1 and
ENPP3, are NPP-type ectophosphodiesterases, and thus are
involved in the hydrolysis of extracellular ATP to AMP24. NT5E/
CD73, the only 5′-ectonucleotidase, is regarded as the rate-
limiting enzyme in the generation of extracellular adenosine
through AMP dephosphorylation. The ALP-family proteins are
the only ectonucleotidases that contribute to all reactions in the
hydrolysis of extracellular ATP to adenosine through ADP and
AMP17. Prostatic acid phosphatase is considered to contribute to
the physiological generation of adenosine through AMP hydro-
lysis, although it is less characterized25. Considering the impor-
tance of their hydrolase activities in extracellular adenine-
nucleotide metabolism, the integrated control of the functions
of ectoenzymes must be operative. However, the molecular
underpinnings of the activation of these enzymes remain mostly
unknown.
Recent crystal structural studies revealed that the ENPP pro-
teins and NT5E/CD73 contain two zinc ions in their active
sites26–31, as in ALP proteins32,33, whereas ENTPD1/CD39 and
PAP do not harbor zinc at the active sites34,35. This raises the
possibility that zinc status is associated with extracellular adenine-
nucleotide metabolism, and thus, with purinergic signaling.
Herein, we test this hypothesis by directly measuring the activities
of these ectoenzymes in cultured cells (both cells endogenously
expressing the enzymes and cells overexpressing the enzymes)
and in rats that were fed zinc-deficient diets.
Results
Effects of zinc deficiency on ATP/ADP/AMP-hydrolyzing
enzyme. We evaluated the zinc dependency of several ectoen-
zymes by expressing the enzymes in chicken DT40 cells and
comparing their activities with that of endogenous Tnap, an
isozyme of ALP36,37. Thus, we expressed ENTPD1/CD39, PAP,
ENPP1, ENPP3, and NT5E/CD73 in DT40 cells (Fig. 2a–g) and
evaluated their dependence on zinc levels in the culture medium
using our previous experimental strategy. The activity of endo-
genous Tnap substantially decreased (>95%) in zinc-deficient
cultures, whereas ENTPD1/CD39 and PAP activities were almost
unchanged (Fig. 2a–d), which is consistent with their recognized
features; ENTPD1/CD39 contains calcium or magnesium, instead
of zinc in the active site34,38, and PAP has been characterized as a
histidine phosphatase35. In contrast, the activity of ENPP1,
ENPP3, and NT5E/CD73 decreased in zinc-deficient cultures
(Fig. 2e–g), although ENPP1 activity decreased only moderately.
Notably, the diminished activity caused by zinc deficiency
recovered completely following zinc supplementation (Fig. 2h–j),
because Chelex-100 (CX), which was used to create zinc defi-
ciency in fetal calf serum (FCS) (see Methods), causes deficiency
of zinc and also several other trace elements, as it can chelate
divalent cations.
To complement the studies conducted using the DT40 cell
overexpression system, we further examined whether the activity
of ENPP1, ENPP3, and NT5E/CD73, as well as that of TNAP, is
altered by zinc levels in generic human cells. Specifically, we
examined ENPP1 (and ENPP3) activity in hepatoma HepG2 cells,
ENPP3 activity in colon carcinoma HT-29-MTX-E12 cells and
KU-812 basophils, NT5E/CD73 activity in pancreatic carcinoma
PANC-1 cells and monocytic leukemia THP-1 cells, and TNAP
activity in chronic myelogenous leukemia-derived HAP1 cells
(Fig. 3a–f) because these are representative cells that express the
corresponding ectoenzymes (Supplementary Fig. 1). KU-812 and
THP-1 cells were used after differentiation because enzyme
expression is enhanced following differentiation. Notably, the
activity of all the measured enzymes substantially decreased in
zinc-deficient cultures, which apparently caused no toxic effects
on the cells (Supplementary Fig. 2), but restored by zinc
supplementation in the medium (Fig. 3a–g). ENPP1 activity
moderately decreased under zinc deficiency in HepG2 cells, as in
ENPP1 overexpressed DT40 cells, whereas ENPP3 activity was
affected significantly in HT-29-MTX-E12 and KU-812 cells. This
suggests that these distinct zinc-responsive effects are due to the
inherent properties of ENPP1 and ENPP3. Collectively, our
findings indicate that the activity of ENPP1, ENPP3, NT5E/
CD73, and TNAP, which are involved in the regulation of
purinergic signaling, decreased under zinc-deficient conditions.
Impaired ATP hydrolysis to adenosine in zinc-deficient cells.
The results described above clearly show that the activity of each
tested ectoenzyme (ENPP1, ENPP3, NT5E/CD73, or TNAP)
depended on the zinc status, but the direct effects of zinc defi-
ciency on adenine-nucleotide hydrolysis from ATP to adenosine
was not clear. Thus, we addressed this point by high-performance
liquid chromatography (HPLC) to directly measure the content of
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each adenine nucleotide and adenosine produced through ATP
hydrolysis by membrane proteins obtained from the cells used in
the preceding set of studies. Under the HPLC conditions used,
ATP, ADP, AMP, and adenosine could be clearly discriminated
(Supplementary Fig. 3a), and the peak areas corresponded to their
specific amounts (Supplementary Fig. 3b). Our results showed
that the amount of ATP remaining and the amount of ADP
hydrolyzed from ATP were significantly higher with the use of
membrane proteins obtained from all cells cultured in zinc-
deficient medium (relative to control medium), whereas the
adenosine content significantly decreased (Fig. 4a–f). However,
their content ratio varied among the cells. These results indicate
that extracellular adenine-nucleotide hydrolysis is impaired by
zinc deficiency in several cell types, thus delaying both ATP
clearance and adenosine generation.
A similar profile of ATP, ADP, and adenosine was found in
DT40 cells, but this was significantly altered following the
overexpression of ENTPD1/CD39 and TNAP, but not PAP
(Fig. 4g–j). When ENTPD1/CD39 was overexpressed, the content
of ATP and ADP depleted even under zinc-deficient conditions,
whereas the adenosine content was almost unaltered, and these
changes were accompanied by an increase in AMP content,
compared with those in wild-type (WT) DT40 cells (Fig. 4g, h). In
contrast, the overexpression of TNAP decreased the content of
ATP, ADP, and AMP, except under zinc-deficient conditions,
and thus reinforcing the effect of zinc deficiency on ATP
hydrolysis (Fig. 4g, j). Collectively, our results suggest that the
effects of zinc status on extracellular adenine-nucleotide meta-
bolism are regulated by the expression pattern and level of
ENTPD1/CD39, TNAP, ENPP1, ENPP3, and NT5E/CD73, with
the contribution of PAP probably being negligible. Moreover,
these findings indicate that zinc deficiency significantly affects
adenosine generation in all the cells, likely reflecting the
hydrolysis of AMP primarily by NT5E/CD73 and TNAP, which
require zinc as an essential cofactor.
Impaired ATP hydrolysis in rat plasma by zinc deficiency. To
investigate how zinc deficiency affects the activity of the afore-
mentioned ectoenzymes in vivo, we obtained plasma from rats
that were fed a zinc-deficient (Zn-Def), low-zinc (Zn-Low), or
zinc-sufficient (Zn-Suf) diet (2.2, 4.1, or 33.7 mg zinc per kg,
respectively) (Fig. 5a–e). The ectoenzymes are all located on the
cell surface, but most of them are also known to be present in the
plasma. NT5E/CD73 and TNAP (and other ALPs) are released
into the circulation through the hydrolysis of glycosylpho-
sphatidylinositol anchor29,33, and ENPP1 and ENPP3 are con-
verted into soluble forms through proteolytic cleavage24.
Intriguingly, plasma Enpp (probably Enpp1 and Enpp3) activity
significantly diminished one day after feeding the rats with Zn-
Low and Zn-Def diets (Fig. 5a), which almost mirrored the
reduction in plasma zinc concentrations in the rats of the Zn-Low
and Zn-Def groups (Fig. 5d). Moreover, plasma activities of Alp
(Tnap and other Alps) and Nt5e/Cd73 were significantly lower on
day 3 after feeding the rats with Zn-Def and/or Zn-Low diets,
compared with those in the Zn-Suf group (Fig. 5b, c). In accor-
dance with these results, the rate of ATP hydrolysis was sig-
nificantly altered in the plasma of rats in the Zn-Low and Zn-Def
groups compared with that in the Zn-Suf group (Fig. 5e).
We then investigated how milder zinc deficiency (4.0, 6.0, and
8.0 mg zinc per kg) over a longer period (10 days) (relative to that
in the preceding experiment) affected both ectoenzyme activities
and adenine-nucleotide and adenosine content (Fig. 5f–k). The
activities of Enpp, Alp, and Nt5e/Cd73 decreased in the plasma of
rats that were fed tested zinc-deficient diets, with the order of
activity reduction corresponding to zinc content in the diets
(Fig. 5f–h). The order also agreed with the measured rate of ATP
hydrolysis, which substantially changed in all the rats that were
fed the zinc-deficient diets (Fig. 5j). Moreover, in the hydrolysis
experiment, we examined the effect on ATP hydrolysis to
adenosine in the rat plasma by quantifying the content of each
adenine nucleotide and adenosine by HPLC. The results were
almost identical to those obtained in the cell culture study. The
amount of ATP remaining and ADP hydrolyzed from ATP
markedly increased and the adenosine content significantly
decreased in the plasma of rats from all groups that were fed
the zinc-deficient diets (Fig. 5k).
Lastly, we examined whether the reduced enzyme activity in
the plasma of rats that were fed tested zinc-deficient diets
reversed by zinc-sufficient diets. The activity of Enpp, Alp, and
Nt5e/Cd73 significantly decreased in the plasma four days after
feeding the rats with the Zn-Low (4.0 mg zinc per kg) diet, which
was reversed by the Zn-Suf (33.7 mg zinc per kg) diet for only one
day (Fig. 6a–c). These results mirrored the alteration in plasma
zinc concentrations (Fig. 6d), and inversely mirrored the rate of
ATP hydrolysis (Fig. 6e). These results suggest that dietary zinc
deficiency delays both extracellular ATP clearance and adenosine
generation by reducing the activity of ectoenzymes, such as
NT5E/CD73, ENPP, and ALP, and thus strongly affects the
purinergic signaling cascade in vivo.
Mechanisms underlying ENPP1, ENPP3, and NT5E/CD73
activation. The reduced activity of Enpp, Nt5e/Cd73, and Alp
and the rate of ATP hydrolysis in the plasma of rats that were fed
the Zn-Def diet were not reversed after incubation with excess
zinc (Fig. 7a–d). The same results were found with regard to the
reduced activity of ENPP1, ENPP3, NT5E/CD73, and TNAP
obtained from the zinc-deficient cells (Fig. 7e–h). The results
indicate that these ectoenzymes are activated in the early secre-
tory pathway39,40. Our previous in vitro TNAP study using DT40
cells indicated that the activation of TNAP requires two zinc-
transporter complexes consisting of ZNT5–ZNT6 heterodimers
and ZNT7 homodimers, which are localized in the early secretory
pathway. Thus, Tnap activity was substantially decreased in
chicken DT40 cells deficient in znt5, znt6, and znt7 (triple-
knockout cells; TKO cells)41, which suggests that the activities of
ENPP1 or ENPP3 and NT5E/CD73 are regulated in a similar























Fig. 1 Ectoenzymes involved in extracellular adenine-nucleotide metabolism. ATP, ADP, and adenosine trigger purinergic signaling by binding to ionotropic
P2X, metabotropic P2Y, and P1 receptors. ATP is hydrolyzed to ADP, AMP, and adenosine, with the hydrolysis being mediated by several ectoenzymes. P2
and P1 receptors frequently transduce signals that produce opposite effects. Representative ectoenzymes are shown in the box on the right
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Fig. 2 Marked reduction of ENPP1, ENPP3, and NT5E/CD73 activities in zinc-deficient cultures. a ENTPD1/CD39 activity in chicken DT40 cells was not
impaired by zinc deficiency. ENTPD1/CD39 activity was evaluated from the relative amount of ATP remaining after ATP hydrolysis. b Endogenous Tnap
activity was severely reduced in the cells used in a. c PAP activity in chicken DT40 cells was not impaired by zinc deficiency. d Endogenous Tnap activity
was severely reduced in the cells used in c. e ENPP1, f ENPP3, and g NT5E/CD73 activities significantly decreased in zinc-deficient cultures. In a–g, the
activity of each enzyme was measured using membrane proteins obtained from cells cultured in normal medium, CX (Chelex) medium (zinc-deficient
medium), or CX medium supplemented with 4 or 20 µM ZnSO4 for 24 h. The zinc-deficiency-induced reduction in the activities of h ENPP1, i ENPP3, and
j NT5E/CD73 was reversed following zinc supplementation. The cells were cultured in CX medium for 12 or 24 h, and then supplemented with 20 µM
ZnSO4 for a final 24 h. In a–j, all activities are expressed as the mean ± SD of triplicate experiments. Representative results from three independent
experiments are displayed. Expression of each enzyme was confirmed by immunoblotting (lower panels). Calnexin (Cnx) is shown as a loading control.
Full-length immunoblots are shown in Supplementary Fig. 7
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The ENPP-family proteins feature a two-zinc-ion-centered
geometry at their active site, which resembles that of ALP
proteins, including TNAP26–28,33. This suggests that the activity
of ENPP1 and ENPP3 depends on ZNT5–ZNT6 heterodimers
and ZNT7 homodimers, and thus the enzymes are not activated
in TKO cells, similar to that of its homolog ENPP2 (also called
autotaxin)37, which does not significantly contribute to extra-
cellular adenine nucleotide hydrolysis (Supplementary Fig. 4a).
Unexpectedly, however, the activity of neither ENPP1 nor ENPP3
decreased in TKO cells stably expressing each of the enzymes
(Fig. 8a, b). We also expressed ENPP1 and ENPP3 in quadruple-
knockout (QKO) cells37, which lacked znt4 in addition to znt5,
znt6, and znt7, because the activity of another zinc-requiring
ectoenzyme, carbonic anhydrase IX, decreased when expressed in
QKO cells37. We also found that the activity of ENPP1 and
ENPP3 was not altered (Fig. 8c, d), although their activities
decreased in zinc-deficient cultures (Fig. 8e, f). This suggests
that both ENPP1 and ENPP3 can acquire zinc through an
additional pathway that is independent of all ZNT5–ZNT6
heterodimers, ZNT7 homodimers, and ZNT4 homodimers. This
conclusion is in sharp contrast to that of ENPP2 because its
activity almost completely decreased when expressed in TKO
cells37. The differences between them are explained by the unique
sequence features of ENPP2 because the substitution mutations of
ENPP2 resulted in the gain of adenine nucleotide hydrolysis
activity and ZNT transporter independency (Supplementary
Fig. 4b–e).
Next, we conducted the same experiment on NT5E/CD73. In
contrast to ENPP1 and ENPP3, NT5E/CD73 showed a marked
reduction in activity in TKO cells, and its protein was not
detected (Fig. 8g, h). Furthermore, NT5E/CD73 activity in TKO
cells was restored following either coexpression of ZNT5 and
ZNT6 or expression of ZNT7, although the restored NT5E/CD73
activity was lost when the cells were cultured in zinc-deficient
medium (Fig. 8i, j). However, NT5E/CD73 activity in TKO cells
failed to recover following the subsequent zinc supplementation
in the culture medium (Fig. 8k). Thus, NT5E/CD73 is specifically
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Fig. 3 Regulation of ENPP1 or ENPP3 and NT5E/CD73 activities by zinc in human cells. Endogenous ENPP1, ENPP3, NT5E/CD73, and TNAP activities in
human cells decreased in zinc-deficient cultures, and this was reversed by zinc supplementation. Enzyme activities were measured (as in Fig. 2) using
a HepG2 cells for ENPP1 and ENPP3, b HT-29-MTX-E12 cells for ENPP3, c KU-812 cells for ENPP3, d PANC-1 cells for NT5E/CD73, e THP-1 cells for NT5E/
CD73, and f HAP1 cells for TNAP. All activities are shown as mean ± SD of triplicate experiments. Representative results from three independent
experiments are displayed. The expression of each protein was confirmed by immunoblotting (lower panels). Calreticulin (CALR) is shown as a loading
control. Full-length immunoblots are shown in Supplementary Fig. 8
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Fig. 4 Effect of zinc status on ATP hydrolysis to adenosine. The content of ATP, ADP, AMP, and adenosine was measured after the ATP-hydrolysis reaction
using membrane proteins, which were obtained from the human cell lines mentioned in Fig. 3 and from chicken DT40 cells. The cells used were a HepG2,
b HT-29-MTX-E12, c KU-812, d PANC-1, e THP-1, f HAP1, g DT40, h DT40 overexpressing ENTPD1/CD39, i DT40 overexpressing PAP, and j DT40
overexpressing TNAP, which were cultured in normal medium, CX medium, or CX medium supplemented with 4 or 20 µM ZnSO4 for 24 h. In all cases
a–j, the content of ATP, ADP, AMP, and adenosine was measured by separating them by HPLC for 20min after hydrolysis of 200 μM ATP and then
calculating the area under the corresponding peaks. The absolute amount of each molecule was calculated from the standard curves of ATP, ADP, AMP,
and adenosine (Supplementary Fig. 3). Values are presented as mean ± SD of three experiments. Whereas ATP and/or ADP content increased, the
adenosine content decreased in zinc-deficient cultures (CX). This was reversed by zinc supplementation (4 or 20 µM ZnSO4)
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in the case of TNAP36. The same ZNT transporter-dependent
activity was found in an ALP isozyme, placental ALP (PLAP),
when expressed in TKO cells (Supplementary Fig. 5). Collectively,
these findings suggest that the zinc-mediated activation of ENPP1
and ENPP3, NT5E/CD73, PLAP, and TNAP is not uniform at the
molecular level, but regulated in a complex manner, and that
ZNT5–ZNT6 heterodimers and ZNT7 homodimers significantly
contribute to extracellular adenine-nucleotide metabolism via
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Fig. 5 Effect of zinc deficiency on adenine-nucleotide metabolism in rat plasma. a Npp, b Nt5e/Cd73, and c Alp activities, and d zinc concentrations in rat
plasma were measured. e ATP hydrolysis was performed using the rat plasma, and the remaining ATP was then evaluated and is expressed relative to the
amount on Day 0. The plasma was obtained from the rats that were fed Zn-Def, Zn-Low, or Zn-Suf diet for up to 4 days. In a–e, values are presented as
mean ± SD (n= 4). f–j Alp, Nt5e/Cd73, and Enpp activities, zinc concentrations, and ATP-hydrolysis rate (remaining ATP) were measured in the plasma of
rats that were fed the diet containing 33.7, 4.0, 6.0, or 8.0 mg zinc per kg for 10 d. k The content of ATP, ADP, AMP, and adenosine after the ATP-
hydrolysis reaction was measured as in Fig. 4. In f–k, values are presented as mean ± SD (n= 5)
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Discussion
To the best of our knowledge, this is the first study indicating that
zinc deficiency significantly affects the activities of four ectoen-
zymes, ENPP1, ENPP3, NT5E/CD73, and TNAP, involved in the
hydrolysis of extracellular ATP to adenosine through ADP and
AMP. The detailed and focused analyses performed on ectoen-
zyme activity, using both in vitro cell-based studies and in vivo
studies, can help elucidate the association of zinc status with
purinergic signaling. Our findings were obtained using two
approaches: Firstly, by directly examining the activity of each
enzyme and secondly by quantifying the content of each adenine
nucleotide and adenosine produced through ATP hydrolysis. In
both the approaches, we used membrane proteins obtained from
cells endogenously expressing or overexpressing the ectoenzymes,
and we also used the plasma obtained from rats that were fed a
diet containing different amounts of zinc. Notably, in this study,
the cells that we used were made zinc-deficient in a physiologi-
cally relevant manner by using Chelex-100 (CX)-treated FCS, and
not by using a nonphysiological equimolar amount of a potent
zinc chelator such as N,N,Nʹ,Nʹ-tetrakis-(2-pyridylmethyl)-ethy-
lenediamine, and the rats were made zinc-deficient by feeding
them marginally zinc-deficient diets (such as 8.0 mg zinc per kg).
Thus, the zinc status can alter extracellular adenine-nucleotide
metabolism and is therefore strongly associated with the main-
tenance of good health and disease pathogenesis.
Limited information indicates that zinc status is associated with
extracellular adenine-nucleotide metabolism, thus leading to the
association with purinergic signaling. However, there is some
evidence suggesting their association. Both ATP/ADP and ade-
nosine are widely recognized to mediate opposite physiological
effects, such as pain signaling by ATP and ADP vs. pain relief by
adenosine, and pro-inflammatory effects of ATP vs. anti-
inflammatory effects of adenosine; zinc alleviates pain42,
whereas zinc deficiency is associated with pain43. Zinc is also a
potent anti-inflammatory nutrient, and its deficiency leads to a
pro-inflammatory state9. Moreover, zinc supplementation has
been shown to ameliorate some defects associated with the loss of
zinc-requiring ectoenzymes involved in extracellular adenine-
nucleotide metabolism. Zinc masks dermatitis, whereas severe
acrodermatitis is caused by decreased Langerhans cells that highly
express ENTPD1/CD39 44,45. Zinc can promote non-REM
sleep46, whereas defective non-REM sleep responses to sleep
deprivation are found in Nt5e/Cd73-KO mice47. Zinc can prevent
diarrhea48, whereas allergen-induced diarrhea (inflammatory
diarrhea) is found in Enpp3-KO mice49. All the diverse zinc-
deficient phenotypes could not be explained by the dysfunction of
extracellular adenine-nucleotide metabolism, but this information
supports the results obtained in this study.
The quantification of each adenine nucleotide and adenosine
hydrolyzed from ATP revealed that the effects of zinc deficiency
varied depending on the cell type, which can be attributed to the
distinct expression pattern and level of ENTPD1/CD39, ENPP1,
ENPP3, NT5E/CD73, TNAP, PAP, and their isozymes (see
Fig. 3). For example, both high expression of TNAP, ENPP1,
ENPP3, and NT5E/CD73 and low expression of ENTPD1/CD39
increase the susceptibility of cells to the effects of zinc deficiency
on extracellular adenine-nucleotide metabolism. In particular, our
results strongly suggest that adenosine generation is readily
affected by zinc deficiency. This could be why zinc deficiency
symptoms do not appear uniformly in the body. Moreover, the
expression pattern of ZNT5–ZNT6 heterodimers and ZNT7
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Fig. 6 Rapid restoration of adenine-nucleotide metabolism in the plasma of rats that were fed zinc-deficient diets with 1-day zinc supplementation. a Npp,
b Nt5e/Cd73, c Alp activities, and d zinc concentrations in the rat plasma were measured. e ATP hydrolysis was performed using the rat plasma, and the
remaining ATP was then evaluated and is expressed relative to the amount on Day 0. The plasma was obtained from the rats that were fed a diet
containing 4.0 mg zinc per kg for 4 days or a diet containing 33.7 mg zinc per kg for 1 day after feeding a diet containing 4.0mg zinc per kg for 4 days. In
a–e, values are presented as mean ± SD (n= 3)
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deficiency, because both zinc-transporter complexes are indis-
pensable for the activity of TNAP and NT5E/CD73 (see Fig. 8).
Another intriguing aspect that was revealed in this study is that
zinc-requiring ectoenzymes show distinct ZNT transporter
dependencies for their activation and furthermore exhibit dif-
ferences in their susceptibility to zinc deficiency. For example,
both ENPP1 and ENPP3 lost their activity under zinc-deficient
conditions, with ENPP3 activity being affected more drastically
(see Figs. 2e, f and 3a–c). Moreover, ENPP1 and ENPP3 did not
lose their activity even when expressed in TKO and QKO cells
(see Fig. 8a–d). This ZNT transporter independency of ENPP1
and ENPP3 is particularly interesting because the activity of their
homolog ENPP2 is completely dependent on ZNT transporters37.
However, the differences can be explained by the unique sequence
of ENPP2 (Supplementary Fig. 4b–e). In contrast, NT5E/CD73 is
completely dependent on ZNT transporters for both its activity
and stability, as in the case of TNAP36 and PLAP (Supplementary
Fig. 5). These results provide an interesting and important
hypothesis that the ZNT transporter-dependent activation of each
ectoenzyme is not defined by the manner of zinc coordination at
the active site of zinc-requiring ectoenzymes, but rather by the
functional role in physiology. Further investigation is required to
clarify this, which provides a new direction for the therapeutic
potential of zinc.
In conclusion, our findings have revealed that zinc deficiency
potently decreases the activities of extracellular adenine-
nucleotide-hydrolyzing ectoenzymes, delaying both extracellular
ATP clearance and adenosine generation. These ectoenzymes are
activated by zinc in the early secretory pathway, but the activation
mechanism is not uniform. Our current results provide novel
insight into why zinc deficiency produces diverse symptoms,
considering that defects in purinergic signaling frequently result
in similar phenotypes, although not all zinc-deficiency-related
phenotypes can be explained by the effect on nucleotide meta-
bolism. The results partly justify why attention should be paid to
zinc deficiency to achieve good health.
Methods
Cell culture. Chicken B lymphocyte-derived DT40 cells were maintained in
RPMI1640 (Nacalai Tesque, Kyoto, Japan) supplemented with 10% heat-
inactivated FCS (Multiser, Trace Scientific, Melbourne, Australia), 1% chicken
serum (Life Technologies, Grand Island, NY, USA), and 10 μM 2-mercaptoethanol
(Sigma, St. Louis, MO) at 39.5 °C. HT-29-MTX-E12 cells (DS Pharma Biomedical,
Co., Ltd, Osaka, Japan) and HepG2 cells were maintained at 37 °C in a humidified
5% CO2 incubator; the culture medium used was Dulbecco's Modified Eagle's
medium (DMEM) (Sigma) containing 10% heat-inactivated FCS, 100 U/mL
penicillin, and 100 μL/mL streptomycin. Rather than DMEM, RPMI1640 medium
was used to maintain KU-812 cells (JCRB Cell Bank, Osaka, Japan), PANC-1 cells
(provided by Dr. Shuichi Enomoto, Okayama University, Japan), and THP-1 cells
(JCRB Cell Bank), and IMDM was used for HAP1 cells (Horizon, Cambridge, UK).
KU-812 and THP-1 cells were used after differentiation into basophilic or
macrophage-like cells by means of serum-free culture for 72 h or treatment for 48 h
with 30 nM (18.5 ng/mL) phorbol 12-myristate 13-acetate (PMA; Wako Pure
Chemicals, Osaka, Japan), respectively. To generate zinc-deficient culture medium,
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Fig. 7 Lack of alteration of enzyme activities in both cell membrane fraction and rat plasma after incubation with zinc. a–d Rat plasma (Day 4) was
incubated with 20 μM ZnSO4 (final concentration) at 4 °C for 24 h and then used to measure the activity of Enpp, Nt5e/Cd73, and Alp. The remaining ATP
was also evaluated. e–h Membrane proteins obtained from cells expressing e ENPP1, f ENPP3, g NT5E/CD73, or h TNAP, which were cultured in normal
medium or CX (Chelex) medium (zinc-deficient medium), were incubated with 20 μM ZnSO4 (final concentration) at 4°C for 4 h, and then used to
measure enzyme activities. All activities are expressed as mean ± SD of triplicate experiments. Representative results of three independent experiments are
displayed. Full-length immunoblots are shown in Supplementary Fig. 9
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removed by filtration. For zinc-supplementation experiments, the cell culture
medium containing the indicated concentrations of ZnSO4 was added. In the
Alamar Blue assay, the cells were inoculated at a density of 1 × 104 cells per mL in
96-well plates and treated with ZnSO4 at the indicated concentrations for one day,
and then Alamar Blue reagent (AbD Serotec, Ltd, Oxford, UK) was added to the
culture medium and incubated for 4 h. Relative proliferation rate was calculated
based on the absorbance at 570 and 600 nm in the medium, according to the
protocol of the manufacturer.
Plasmid construction and transfection into DT40 cells. The fragment con-
taining human NT5E/CD73 cDNA or PAP cDNA used in this study was amplified
through the RT-PCR performed using the human skeletal muscle cDNA (DV
Biologics, Costa Mesa, CA) or human pancreatic islet cDNA (Cosmo Bio Co. Ltd,
Tokyo, Japan) as the template, and inserted into the pA-puro or pA-Ecogpt vector.
The amplified cDNA was sequenced in both directions. The Human ENPP3 cDNA
was purchased from DNAFORM (Tokyo, Japan) and inserted into the pA-puro or
pA-Ecogpt vector. The human ENTPD1/CD39 cDNA was purchased from GE
2500
a b c d
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Healthcare Dharmacon (Buckinghamshire, UK). The plasmids used for the
expression of human TNAP, FLAG-tagged human ZNT5 (FLAG-ZNT5), Halo-
ZNT5, HA-ZNT6, or ZNT7-FLAG was constructed by two-step PCR methods36,50.
All plasmids were linearized with appropriate restriction enzymes. To transfect the
DNA into DT40 cells through electroporation, 1 × 107 cells were suspended in 0.5
mL of cold PBS containing 30 μg of linearized plasmid DNA. DNA was electro-
porated into the cells with a GenePulser Xcell apparatus (Bio-Rad, Hercules, CA,
USA) at 550 V and 25 μF. After electroporation, cells were transferred into 30 mL
−1 of fresh medium and incubated for 24 h. Then, cells were resuspended in 60 mL
of fresh medium containing appropriate drugs and divided into four 96-well plates
for selection. More than three independent stable clones were established per
transfectant in all experiments.
Preparation of membrane proteins. The membrane proteins were obtained from
the cells lysed either in ALP lysis buffer for exclusively measuring TNAP activity, or
in NT5E/CD73 lysis buffer (10 mM Tris-HCl, pH 7.5, 0.5 mM MgCl2, 0.1% NP-40)
to measure ENTPD1/CD39, PAP, NT5E/CD73, ENPP, or TNAP activity.
Measurement of ALP activity. Three micrograms of membrane protein lysed in
ALP lysis buffer or 5 μL of rat plasma were preincubated for 10 min at room
temperature. A 100 μL substrate solution [2 mg/mL disodium p-nitrophenylpho-
sphate hexahydrate (pNPP; Wako Pure Chemicals) in 1 M diethanolamine buffer,
pH 9.8, containing 0.5 mM MgCl2] was added. After incubation for 10 min at room
temperature, the released p-nitrophenol was quantified by measuring the absor-
bance at 405 nm. Calf intestine alkaline phosphatase (Promega, Madison, WI) was
used to generate a standard curve. To measure PLAP activity, the samples were
incubated at 65°C for 30 min to discriminate other activity (PLAP is heat-stable).
pNPP is not hydrolyzed by ENPP or NT5E/CD73 (Supplementary Fig. 6a).
Measurement of ENPP activity. ENPP activity was measured as described else-
where51 with certain modifications. Briefly, 3 μg of membrane proteins or 5 μL of
rat plasma was incubated at 37 °C for 10 min, and then 100 μL of 0.1 mM p-
nitrophenyl thymidine 5′-monophosphate (pNP-TMP; Sigma) solution was added
and incubated at 37 °C for 15 min. p-Nitrophenol released from pNP-TMP by
ENPPs was quantified by measuring the absorbance at 405 nm. Human recombi-
nant ENPP1 (R&D Systems, Minneapolis, MN) was used to generate a standard
curve. pNP-TMP is not hydrolyzed by ENTPD1/CD39, NT5E/CD73, or TNAP
(Supplementary Fig. 6b, f). Specificity of substrates for measuring enzyme activity is
shown in Supplementary Fig. 6.
Measurement of NT5E/CD73 and PAP activity. NT5E/CD73 activity was
measured using a 5′-nucleotidase assay kit (Diazyme Laboratories, Poway, CA)
with 3 μg of membrane proteins or 5 μL of rat plasma. Bovine NT5E/CD73
obtained from serum (Diazyme Laboratories) was used to generate a standard
curve. The activity of PAP and NT5E/CD73, in certain experiments, was evaluated
by the malachite green assay as described elsewhere52, with a few modifications.
Briefly, we incubated 5 μg of membrane proteins in 200 μL of NT5E/CD73 lysis
buffer at 37 °C for 10 min, and the solution was then incubated with 2 mM AMP
(Oriental Yeast Co., Ltd, Tokyo, Japan) at 37 °C for 30 min. Subsequently, the
amount of inorganic phosphate released from AMP was quantified by measuring
the absorbance at 595 nm. For the measurement, 50 μL of the reaction solution was
mixed with 100 μL of Biomol Green Reagent (Enzo Life Sciences, Plymouth
Meeting, PA) and incubated for 10 min at room temperature. The specificity of
NT5E/CD73 activity measured here was confirmed using α,β-methylene-ADP
(Sigma), a selective inhibitor of NT5E/CD73 (Supplementary Fig. 6e). The standard
curve was generated using a solution of Na2HPO4 dissolved in NT5E/CD73 lysis
buffer. Specificity of substrates for measuring enzyme activity is shown in Sup-
plementary Fig. 6.
Measurement of ENTPD1/CD39 (ATP-hydrolysis) activity. The hydrolysis of
ATP was evaluated by the firefly luciferase-based method using the ATP assay
reagent (Toyo Beanet, Tokyo, Japan). We incubated 10 µg of membrane proteins or
10 μL of plasma in 900 μL of HBSS buffer containing 20 mM Hepes at 37 °C for
10 min, and then 100 μL of 1 μM ATP solution was added and the mixture was
incubated at 37 °C for 40 min, and finally the reaction mixture was placed on ice.
For the ATP assay, 50 μL of the reaction solution was used. Firefly luciferase
activity was measured after mixing the mixture by pipetting for 10 s. The amount
of ATP remaining was calculated from the luciferase activity and expressed relative
to that at 0 min. ENTPD1/CD39 does not hydrolyze pNP-TMP (Supplementary
Fig. 6f).
Immunoblotting analysis. Membrane proteins (20 μg) were mixed with 6×
sodium dodecyl sulfate (SDS) sample buffer and then incubated at 37 °C for 10 min
before electrophoresis. Proteins were separated by electrophoresis using 6% or 8%
SDS-polyacrylamide gels. After transfer of proteins to PVDF membranes (Milli-
pore, Bedford, MA), the blots were blocked with PBS containing 4% skimmed milk
and 0.1% Tween-20, and then incubated with the following antibodies diluted in
the blocking solution: anti-HA HA-11 (1:3000; catalog no. MMS-101P; Biolegend,
San Diego, CA), anti-FLAG M2 (1:3000; catalog no. F3165; Sigma), anti-NT5E/
CD73 (1:3000; catalog no. 13160; Cell Signaling Technology, Beverly, MA), anti-
ENPP1 (1:3000; catalog no. NBP2-27561; Novus Biologicals, Littleton, CO), anti-
ENPP3 (1:3000; catalog no. HPA043772; Sigma), anti-ENTPD1/CD39 (1:1000;
catalog no. sc-33558; Santa Cruz Biotechnology, Santa Cruz, CA), anti-PAP
(1:3000; catalog no. P5664; Sigma), anti-calnexin (1:6000; catalog no. ADI-SPA-
860; Enzo Life Sciences), anti-calreticulin (1:5000; catalog no. PA3-900; Affinity
Bioreagents, Golden, CO), anti-TNAP (1:2000; catalog no. sc-30203; Santa Cruz
Biotechnology), anti-ZNT5 (1:2000)36, or anti-placenta alkaline phosphatase L-19
(1:3000; catalog no. sc-15065; Santa Cruz Biotechnology). Immunoreactive bands
were detected with horseradish peroxidase-conjugated anti-mouse or anti-rabbit
secondary antibodies (1:3000; NA931 or NA934; GE Healthcare, Milwaukee, WI),
or anti-goat secondary antibody (catalog no. sc-2020; Santa Cruz Biotechnology),
and fluoro-images were obtained using ImageQuant LAS500 (GE Healthcare).
RT-PCR. The total RNA was isolated from harvested DT40 cells using Sepasol I
(Nacalai Tesque) and reverse-transcribed using ReverTra Ace (TOYOBO, Osaka,
Japan). The PCR was performed using KOD-FX (TOYOBO). The primer
sequences used in this study are shown in Supplementary Table 1.
HPLC analysis. Either 10 μg of membrane proteins in NT5E/CD73 lysis buffer or 25
μL of plasma was incubated with ATP (at a final concentration of 200 μM in lysates
prepared using 100mM Tris-HCl, 0.5 mM CaCl2, 0.5mMMgCl2, pH 7.5) at 37°C for
2 h (for DT40 cells and plasma) or 4 h (for human cell lines), and the samples were
then stored on ice. To separate ATP, ADP, and AMP as single peaks, analyses were
performed using an Inertsil ODS-SP column (5 µm, 4.6mm× 250mm; GL Sciences
Inc., Tokyo, Japan), with a linear gradient (65% buffer containing 20mM NH4H2PO4
and 12.5mM tetra-n-butylammonium hydroxide plus 35% methanol) at 35 °C for
20min, on a Chromaster HPLC system (Hitachi High-Technologies Corp., Tokyo,
Japan). The flow rate was maintained at 0.7mL/min, and sample elution was mon-
itored at 260 and 220 nm (with 220 nm being used to trace possible contaminants). A
commercially available adenosine kit (Jena BioScience GmbH, Jena, Germany) was
used to prepare the standard curve, and the content of ATP, ADP, AMP, and ade-
nosine was calculated from the standard curve based on the HPLC peak area of the
absorbance at 260 nm.
Animal care and dietary zinc manipulation. Four-week-old male Sprague-
Dawley rats were purchased from Japan SLC (Hamamatsu, Japan), and acclimated
for 3 days on the Zn-Suf diet. After acclimation, the rats were divided into three
groups and fed one of these diets for 4 days: Zn-Def, Zn-Low, and Zn-Suf diets,
which contained 2.2, 4.1, and 33.7 mg zinc per kg, respectively53 (Experiment 1). In
another experiment, the rats were divided into four groups, after which they were
allowed to acclimate for 4 days and fed one of these diets for 10 days: 4.0, 6.0, 8.0,
and 33.7 mg zinc per kg diets (Experiment 2). Alternatively, the rats were divided
into two groups, after which they were allowed to acclimate for 3 days, and fed a
diet containing 4.0 mg zinc per kg for 4 days, or a diet containing 33.7 mg zinc per
kg for 1 day after feeding the diet containing 4.0 mg zinc per kg for 4 days
(Experiment 3). The rats were housed in individual stainless-steel cages under
controlled conditions (temperature, 23 ± 2 °C; humidity, 50 ± 10%; 12:12-h
light–dark cycle, 08:00 AM to 08:00 PM), and were sacrificed through decapitation
after being food-deprived for 5 h. Blood samples were collected at the time points
specified in each experiment and used to measure enzyme activity and zinc
Fig. 8 Contribution of ZNT transporters to NT5E/CD73 activity, but not ENPP1 or ENPP3 activity. a–d ENPP1 and ENPP3 activities did not decrease in either
TKO or QKO cells. e, f ENPP1 and ENPP3 activities decreased in QKO cells that were cultured under zinc-deficient conditions, but this was reversed by zinc
supplementation. g NT5E/CD73 activity significantly decreased in TKO cells. NT5E/CD73 mRNA was expressed at almost the same level in WT and TKO
cells, but NT5E/CD73 was not detected in TKO cells. h Endogenous Tnap activity in the cells used in g is shown for comparison. i NT5E/CD73 activity in
TKO cells was restored by coexpressing ZNT5 and ZNT6 or expressing ZNT7; this restoration of NT5E/CD73 activity by ZNT5–ZNT6 heterodimers or
ZNT7 homodimers required zinc in the medium. N: Normal medium; CX: zinc-deficient medium; Zn: medium supplemented with 20 µM ZnSO4.
j Endogenous Tnap activity in the cells used in i is shown for comparison. k Zinc supplementation did not restore the activity of NT5E/CD73 expressed in
TKO cells; the cells were cultured with 0, 40, or 80 μM ZnSO4 for 24 h. All enzyme activities shown in a–k were measured and are expressed as in Fig. 2.
Representative results from three independent experiments are displayed. The expression of each protein was confirmed by immunoblotting (lower
panels). Calreticulin (Calr) or calnexin (Cnx) is shown as a loading control. Full-length immunoblots are shown in Supplementary Figs. 10 and 11
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concentration in the plasma. For zinc-supplementation experiments using rat
plasma, the plasma was incubated with 20 μM ZnSO4 (final concentration) for 24 h
and then used to measure enzyme activities. The experimental protocol for this
study was approved by the Animal Research-Animal Care Committee of Tohoku
University and Kyoto University, and all animal experimental procedures were
implemented in accordance with the guidelines issued by this committee and the
Japanese governmental legislation (2005). The same committee also supervised the
care and use of the rats used in this study.
Statistical analyses. All data are presented as mean ± SD. Statistical significance
was assessed by the one-way analysis of variance followed by Tukey’s test and
accepted at P < 0.05 (*) or P < 0.01 (**).
Data availability. All data generated or analyzed during this study are included in
this published article (and its supplementary information files) or are available
from the authors upon reasonable request. Full-length immunoblots corresponding
to images in the main and supplementary figures are shown in Supplementary
Figs. 7–15.
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